Heartflow, Inc. Royalty Expense
Heartflow, Inc. (HTFL) reported Royalty Expense of $723.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-08-13
- Heartflow, Inc. royalty expense for the quarter ending 2026-06-30 was $723.00K, a 57.17% increase year-over-year.
- Heartflow, Inc. royalty expense for the quarter ending 2026-03-31 was $568.00K, a 37.20% increase year-over-year.
- Heartflow, Inc. royalty expense for the quarter ending 2025-12-31 was $500.00K, a 66.67% increase year-over-year.
- Heartflow, Inc. royalty expense for the quarter ending 2025-09-30 was $586.00K, a 36.92% increase year-over-year.
- Heartflow, Inc. royalty expense for fiscal 2025 was $2.00M, a 33.33% increase from fiscal 2024.
- Heartflow, Inc. royalty expense for fiscal 2024 was $1.50M, a 28.57% decline from fiscal 2023.
- Heartflow, Inc. royalty expense for fiscal 2023 was $2.10M.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $723.00K 10-Q · filed 2026-08-13 | $1.30M 10-Q · filed 2026-08-13 | $1.79M derived: sum of 3 quarters · filed 2026-08-13 | $2.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $568.00K 10-Q · filed 2026-05-14 | $1.07M derived: sum of 2 quarters · filed 2026-05-14 | $1.65M derived: sum of 3 quarters · filed 2026-05-14 | $2.11M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.09M derived: sum of 2 quarters · filed 2026-03-18 | $1.55M derived: sum of 3 quarters · filed 2026-08-13 | $2.00M 10-K · filed 2026-03-18 |
| 2025-09-30 | $586.00K 10-Q · filed 2025-11-12 | $1.05M derived: sum of 2 quarters · filed 2026-08-13 | $1.50M 10-Q · filed 2025-11-12 | $1.76M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $460.00K 10-Q · filed 2026-08-13 | $874.00K 10-Q · filed 2026-08-13 | $1.17M derived: sum of 3 quarters · filed 2026-08-13 | $1.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $414.00K 10-Q · filed 2026-05-14 | $714.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.14M derived: sum of 3 quarters · filed 2026-05-14 | $1.56M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $728.00K derived: sum of 2 quarters · filed 2026-03-18 | $1.14M derived: sum of 3 quarters · filed 2026-03-18 | $1.50M 10-K · filed 2026-03-18 |
| 2024-09-30 | $428.00K 10-Q · filed 2025-11-12 | $842.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.20M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $414.00K 10-Q · filed 2025-09-19 | $750.00K 10-Q · filed 2025-09-19 | ||
| 2023-12-31 | $2.10M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |